Translational relevance
Introduction

75
Chemotherapy, alone or in combination with other treatment modalities, is widely used in Immunohistochemistry and evaluation of staining 148 After antigen retrieval and blocking with normal serum, the slides were incubated overnight 149 at 4 ºC with the primary antibody against E2F1 (#SC-251, Santa Cruz Biotechnology, Santa 150 Cruz, CA) followed by biotinylated secondary antibodies and peroxidase-conjugated avidin-151 biotin complex. Immunostaining was visualized using 3, 3'-diaminobenzidine (DAKO) as 152 chromogen, and then the sections were counterstained with hematoxylin. The E2F1 153 immunostaining in the TMA was assessed using a grading system based on the percentage of 154 positive nuclei (13): 0, no nuclear staining; 1, < 10% positive staining; 2, 10-50%; 3, > 50%.
155
Immunostaining of IGF2 was performed with an anti-human IGF2 antibody (#AF-292-NA) 9 from R&D Systems (Minneapolis, MN;) and evaluated as described previously (1) .
157
Specimens assigned scores of 0 to 1 were considered weak, whereas scores 2 to 3 were 158 considered strong. GSE47404, GSE13898, GSE37203, GSE28000, GSE28722, GSE10141, GSE45436,
165
GSE54236, GSE3141, GSE7849, GSE50948). R scripting was used to extract the expression 166 values of genes of interests and clinical data from the data matrices as described by Yuen et 167 al (23, 24) . Gene expressions were further divided into high and low levels using median 168 expression level as the cut-off point for Kaplan-Meier survival analyses.
170
Statistical analysis
171
The data were expressed as the mean ± SD and compared using ANOVA. The expression 172 level of Id1, E2F1, and IGF2 in tumor samples and matched normal samples was compared Fisher's Exact tests, respectively. The association between the expression level and patient 176 survival was plotted using the Kaplan-Meier method, and statistical differences were 177 compared using the log-rank test. P values < 0.05 were deemed significant. All in vitro 178 experiments and assays were repeated at least three times. (Fig. 1D) . Increased mRNA expression levels of Id1 and IGF2, but 198 not E2F1, were observed in the FR cells (Fig. 1E ). ESCC cells with E2F1 overexpression or 199 knockdown were treated with 5-FU, and then cell proliferation was measured. As expected,
200
ectopic expression of E2F1 increased TS expression and 5-FU chemoresistance, whereas 201 repressed expression of E2F1 had the opposite effects ( Supplementary Fig. S2 ). These 202 findings strongly support the rationale of using these FR sublines as cell models for we found that Id1 overexpression induced ( Fig. 2A) , whereas Id1 knockdown reduced (Fig.   220 2B), the expression levels of E2F1 and TS dose-dependently. The rescue experiments showed 221 that the induction of TS by Id1 was abrogated by two different shRNAs against E2F1 (Fig.   222 2C, left), and that E2F1 overexpression restored the TS expression in Id1-repressed ESCC 223 cells (Fig. 2C, right) . In addition, higher Id1 and E2F1 expressions were observed in the 224 majority of tumors compared with the corresponding normal tissues (Supplementary Fig. S4 ).
225
There was also a positive correlation between expressions of Id1 and E2F1 in the 50 pairs of 226 ESCC and normal esophageal tissues (Fig. 2D) . Furthermore, our in vitro functional assays (Fig. 2F, left; Supplementary Figure S5A ).
233
Conversely, although 5-FU treatment had no effect on growth of tumors derived from FR Flag-Cdc20 and HA-Id1, and found that Cdc20 and Id1 were indeed interacting partners in 250 esophageal cancer cells (Fig. 3B) . Meanwhile, the physical interaction between Cdc20 and Fig. S8 ). Moreover, 277 the data from RT-PCR analysis showed that E2F1 overexpression increased (Fig. 4B, left) , 278 whereas E2F1 knockdown decreased (Fig. 4B, middle and Table S1 ). Likewise, analysis of colon cancer patient cohort from GEO datasets revealed that The pRb protein, which functionally inactivates E2F1 on one hand but protects it from 402 degradation on the other, was thought to be the most crucial regulator of E2F1 (35). However, Bars, SD; **, P < 0.01; ***, P < 0.001. were co-transfected with HA-tagged Id1 construct or vector control into KYSE150 cells.
639
Immunoprecipitation assay was performed on the cell lysates using an anti-Flag antibody or
640
IgG as a control, followed by Western blot to detect protein expressions. E, a proposed model 
